Turn Therapeutics Inc. (TTRX)
Market Closed
23 Sep, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
13. 51
-1.78
-11.6416%
$
456.95M Market Cap
- P/E Ratio
- Div Yield
101,600 Volume
- Eps
$ 15.29
Previous Close 
Want to track TTRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Turn Therapeutics NASDAQ: TTRX outlined the final stage two design and data-driven expansion of its GX-03 phase II program in atopic dermatitis during an investor update call, saying the revised approach was informed by an interim analysis of the first 50 completers in the ongoing trial.
Marketbeat | 2 months ago
